Single Technologies
Single Technologies develops Theta, a 3-D Sequencing platform that utilizes a multi-layered cube structure to increase the number of DNA sequences read in parallel. The technology enables high-throughput DNA analysis for both in situ and solution-based sequencing, specifically targeting applications in genomics, proteomics, and spatial biology. The system allows researchers to sequence directly within cells to gain higher read counts and analyze more cells per run.
Healthtech
Biotechnology
Genomics
Life Sciences
Funding summary
- Total raised
- €18.8M
- Funding rounds
- 3
Investors in Single Technologies
Investors on record for Single Technologies. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Single Technologies?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors